ARTICLE | Clinical News
Tolcapone: Phase IIa data
November 9, 2015 8:00 AM UTC
An open-label, Spanish Phase IIa trial in 6 healthy volunteers and 15 FAP patients at different stages of disease progression and asymptomatic carriers with mutations in the TTR gene showed that singl...